Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Maus anti-Human IgA2 Antikörper (PE)

ELISA Monoclonal A9604D2 IgG1 PE
Produktnummer ABIN376572

Kurzübersicht für Maus anti-Human IgA2 Antikörper (PE) (ABIN376572)

Target

IgA2

Klonalität

  • 11
  • 2
Monoklonal

Konjugat

  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
PE

Applikation

  • 10
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
ELISA

Klon

A9604D2

Isotyp

IgG1
  • Reaktivität

    Human

    Wirt

    • 11
    • 2
    Maus

    Spezifität

    Human IgA2 Fc, Mr 170 kDa

    Produktmerkmale

    Mouse Anti-Human IgA2-PE

    Aufreinigung

    Purified

    Immunogen

    Purified human IgA2m(1) myeloma protein
  • Applikationshinweise

    • Applications: ELISA - Quality tested , FLISA - Quality tested ELISPOT - Reported in literature , FC - Reported in literature , IHC-FS - Reported in literature , IHC-PS - Reported in literature , WB - Reported in literature , Multiplex - Reported in literature , Sep - Reported in literature , Depletion - Reported in literature
    • Working Dilutions: ELISA AP conjugate 1:1,000 - 1:2,000 HRP conjugate 1:4,000 - 1:16,000 BIOT conjugate 1:5,000 - 1:10,000 FLISA FITC and AF488 conjugates 1:200 - 1:400 PE and AF647 conjugates ≤ 1 g/mL

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    0.1 mg/mL

    Buffer

    0.1 mg in 1.0 mL of PBS/Sodium azide and a stabilizing agent

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Do not freeze!
    Protect conjugated products from light.

    Each reagent is stable for the period shown on the bottle label if stored as directed.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Store at 2-8°C
  • Violari, Cotton, Kuhn, Schramm, Paximadis, Loubser, Shalekoff, Da Costa Dias, Otwombe, Liberty, McIntyre, Babiker, Gibb, Tiemessen: "A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation." in: Nature communications, Vol. 10, Issue 1, pp. 412, (2019) (PubMed).

  • Target

    IgA2
Sie sind hier:
Chat with us!